Jan Buckner is an Oncology physician affiliated with Mayo Clinic. OpenAlex indexes 382 publications with 29,939 citations (h-index 86); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 1st St SW
Rochester, MN 559050001
Telephone
507-284-2511Provider last certified this registry record 21 Nov 2024.
Clinical trials
- Study of Tissue and Blood Samples From Patients With High-Grade Glioma
Sponsor: Alliance for Clinical Trials in Oncology
- Study of Tissue and Blood Samples From Patients With Low-Grade Glioma
Sponsor: Alliance for Clinical Trials in Oncology
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma
Sponsor: Alliance for Clinical Trials in Oncology
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
78%PD-1 inhibitor73.1%Pembrolizumab52%Nivolumab49%Part B, office-administered≥24 patientsProteasome Inhibitor3.3%Bortezomib100%Part B, office-administered≥11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
16%Other antiemetics13%Fosaprepitant100%Part B, office-administered≥12 patientsSerotonin-3 Receptor Antagonist2.9%Ondansetron hydrochloride100%Part B, office-administered≥37 patientsSensory organs
3.9%Corticosteroid3.9%Dexamethasone sodium phosphate100%Part B, office-administered≥40 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 1997–2019 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
Ayalew Tefferi, MD
Mayo Clinic
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”